STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
Reported by STAT News · all stories from statnews.com
Editorial digest
Insitro's Daphne Koller shares insights on how artificial intelligence can make clinical trials faster. This involves leveraging advanced computational methods for drug development.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/26/2026
STAT+: When it comes to women’s health, money talks
Funding is increasing for innovations in women's health.
- Trusted health newsroom8/12/2026
Assort Health rolls out AI agent to automate referrals for specialty practices and health systems - Fierce Healthcare
Assort Health introduces an AI agent to streamline patient referrals for specialty and health systems.
- Trusted health newsroom7/27/2026
Flourish Health secures $26M to scale intensive youth mental healthcare - Fierce Healthcare
Flourish Health raised $26 million to expand youth mental healthcare.
- Trusted health newsroom8/25/2026
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
The FDA will issue new AI regulations; Epic's user meeting also had significant updates.
- Trusted health newsroom8/19/2026
STAT+: What Epic did — and didn’t — say about AI at its annual meeting
Epic's annual meeting covered some AI topics, but omitted others.
- Trusted health newsroom8/25/2026
STAT+: Sword Health to acquire Headspace, according to filing
Sword Health plans to acquire Headspace, based on a recent filing.